Scaffold hopping

Graul, 2003, The year's new drugs, Drug News Perspect., 16, 22

Graul, 2004, The year's new drugs, Drug News Perspect., 17, 43

Clarke, 1973

Sneader, 1996

Teuber, 1999, Ligands for the benzodiazepine binding site – a survey, Curr. Pharm. Des., 5, 317, 10.2174/138161280505230110100242

Andersen, 1990, Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy, Eur. J. Pharm., 2, 335, 10.1016/0922-4106(90)90194-3

Kebabian, 1999, Compounds selective for dopamine receptor subtypes, Drug Discov. Today, 2, 333, 10.1016/S1359-6446(97)01075-1

Lednicer, 2002, Tracing the origins of COX-2 inhibitor structures, Curr. Med. Chem., 9, 1457, 10.2174/0929867023369727

Trummlitz, 2002, Designing selective COX-2 inhibitors: molecular modeling approaches, Curr. Opin. Drug Discov. Dev., 5, 550

Pfau, 2003, Structure-based design of thrombin inhibitors, Curr. Opin. Drug Discov. Dev., 6, 437

Dolle, 1997, Pyridazinodiazepines as a high-affinity, P2-P3 peptidomimetic class of interleukin-1 beta-converting enzyme inhibitor, J. Med. Chem., 40, 1941, 10.1021/jm9701637

Olson, 1993, Concepts and progress in the development of peptide mimetics, J. Med. Chem., 36, 3039, 10.1021/jm00073a001

Ongini, 2001, Selective adenosine A2A receptor antagonists, Farmaco, 56, 87, 10.1016/S0014-827X(01)01024-2

Johnson, 1990

Boehm, 1996, What can we learn from molecular recognition in protein-ligand complexes for the design of new drugs?, Angew. Chem. Int. Ed., 35, 2588, 10.1002/anie.199625881

Kearsley, 1990, An alternative method for the alignment of molecular structures: maximizing electrostatic and steric overlap, Tetrahedron Comput. Methodol., 3, 615, 10.1016/0898-5529(90)90162-2

Klebe, 1999, Methodological developments and strategies for a fast flexible superposition of drug-size molecules, J. Comput. Aided Mol. Des., 13, 35, 10.1023/A:1008026702439

Good, 1996, Three-dimensional structure database searches, vol. 7, 67

Van Drie, 1997, Strategies for the determination of pharmacophoric 3D database queries, J. Comput. Aided Mol. Des., 11, 39, 10.1023/A:1008019326401

Kaminski, 1997, Identification of novel farnesyl protein transferase inhibitors using three-dimensional database searching methods, J. Med. Chem., 40, 4103, 10.1021/jm970291v

De Lucca, 1998, De novo design, discovery and development of cyclic urea HIV protease inhibitors, Drugs Future, 23, 987, 10.1358/dof.1998.023.09.473829

De Esch, 2001, Development of a pharmacophore model for histamine H3 receptor antagonists, using the newly developed molecular modeling program SLATE, J. Med. Chem., 44, 1666, 10.1021/jm001109k

Barreca, 2003, Pharmacophore modeling as an eficient tool in the discovery of novel noncompetitive AMPA receptor antagonists, J. Chem. Inf. Comput. Sci., 43, 651, 10.1021/ci025625q

Langer, 2003, Chemical feature-based pharmacophores and virtual library screening for discovery of new leads, Curr. Opin. Drug Discov. Dev., 6, 370

Kurogi, 2001, Pharmacophore modeling and three-dimansional database searching for drug design using catalyst, Curr. Med. Chem., 8, 1035, 10.2174/0929867013372481

Todorov, 1997, Evaluation of a method for controlling molecular scaffold diversity in de novo ligand design, J. Comput. Aided Mol. Des., 11, 175, 10.1023/A:1008042711516

Stahl, 2002, A validation study on the practical use of automated de novo design, J. Comput. Aided Mol. Des., 16, 459, 10.1023/A:1021242018286

Lloyd, 2004, Scaffold hopping in de novo design. Ligand generation in the absence of receptor information, J. Med. Chem., 47, 493, 10.1021/jm034222u

Makhija, 2004, De novo design and synthesis of HIV-1 integrase inhibitors, Bioorg. Med. Chem., 12, 2317, 10.1016/j.bmc.2004.02.005

Lauri, 1994, CAVEAT: a program to facilitate the design of organic molecules, J. Comput. Aided Mol. Des., 8, 51, 10.1007/BF00124349

Takano, 2003, Computer-aided design of a factor Xa inhibitor by using MCSS functionality maps and a CAVEAT linker search, J. Mol. Graphics Mod., 22, 105, 10.1016/S1093-3263(03)00140-2

Ho, 1993, SPLICE: a program to assemble partial query solutions from three-dimensional database searches into novel ligands, J. Comput. Aided Mol. Des., 7, 623, 10.1007/BF00125322

Pierce, 2004, BREED: generating novel inhibitors through hybridization of known ligands. Application to CDK2, P38 and HIV protease, J. Med. Chem., 47, 2768, 10.1021/jm030543u

Fattori, 2004, Molecular recognition: the fragment approach to lead generation, Drug Discov. Today, 9, 229, 10.1016/S1359-6446(03)03007-1

Erlanson, 2004, Fragment-based drug discovery, J. Med. Chem., 47, 3463, 10.1021/jm040031v

Furet, 2002, Structure-based design and protein X-ray analysis of a protein kinase inhibitor, Bioorg. Med. Chem. Lett., 12, 221, 10.1016/S0960-894X(01)00715-6

Schoepfer, 2002, Structure-based design and synthesis of 2-benzylidene-benzofuran-3-ones as flavopiridol mimics, J. Med. Chem., 45, 1741, 10.1021/jm0108348

Honma, 2003, Recent advances in de novo design strategy for practical lead identification, Med. Chem. Res., 23, 606

Sheridan, 2002, The most common chemical replacements in drug-like compounds, J. Med. Chem., 45, 103

Ertl, 2003, Cheminformatics analysis of organic substituents: identification of the most common substituents, calculation of substituent properties, and automatic identification of drug-like bioisosteric groups, J. Chem. Inf. Comput. Sci., 43, 374, 10.1021/ci0255782

Lewell, 2003, Drug rings database with web interface: a tool for identifying alternative chemical rings in lead discovery programs, J. Med. Chem., 46, 3257, 10.1021/jm0300429

Rarey, 1998, Feature trees: a new molecular similarity measure, J. Comput. Aided Mol. Des., 12, 471, 10.1023/A:1008068904628

Sheridan, 2002, Why do we need so many chemical similarity search methods?, Drug Discov. Today, 7, 903, 10.1016/S1359-6446(02)02411-X

Lengauer, 2004, Novel technologies for virtual screening, Drug Discov. Today, 9, 27, 10.1016/S1359-6446(04)02939-3

Schneider, 2000, De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks, J. Comput. Aided Mol. Des., 14, 487, 10.1023/A:1008184403558

Schneider, 1999, “Scaffold-hopping” by topologocal pharmacophore search: a contribution to virtual screening, Angew. Chem. Int. Ed., 38, 2894, 10.1002/(SICI)1521-3773(19991004)38:19<2894::AID-ANIE2894>3.0.CO;2-F

Schneider, 2000, Virtual screening for bioactive molecules by evolutionary de novo design, Angew. Chem. Int. Ed., 39, 4130, 10.1002/1521-3773(20001117)39:22<4130::AID-ANIE4130>3.0.CO;2-E

Naerum, 2002, Scaffold hopping and optimization towards libraries of glycogen synthase kinase-3 inhibitors, Bioorg. Med. Chem., 12, 1525, 10.1016/S0960-894X(02)00169-5

Rarey, 2001, Similarity searching in large combinatorial chemistry spaces, J. Comput. Aided Mol. Des., 15, 497, 10.1023/A:1011144622059

Lemmen, 2000, Computational methods for the structural alignment of molecules, J. Comput. Aided Mol. Des., 14, 215, 10.1023/A:1008194019144